Site-Specific Binding of Anti-Cancer Drugs to Human Serum Albumin

Author:

Jeelani Ishtiaq12,Bhosale Mrinalini3,Nawaz Allah2,Abe Hitoshi4,Padhye Subhash3

Affiliation:

1. Graduate School of Innovative Life Science, University of Toyama, Toyama 3190, Gofuku 930-8555, Japan

2. Department of Molecular and Medical Pharmacology, Faculty of Medicine, University of Toyama, Toyama 2630, Sugitani 930- 0194, Japan

3. Department of Chemistry, Abeda Inamdar Senior College of Arts, Science and Commerce, Savitribai Phule Pune University, Pune 411001, India

4. Faculty of Engineering, University of Toyama, Toyama 3190, Gofuku 930-8555, Japan

Abstract

Abstract: The interaction of drugs with proteins plays a very important role in the distribution of the drug. Human serum albumin (HSA) is the most abundant protein in the human body and showing great binding characteristics has gained a lot of importance pharmaceutically. It plays an essential role in the pharmacokinetics of a number of drugs and hence several reports are available on the interaction of drugs with HSA. It can bind to cancer drugs and thus it is crucial to look at the binding characteristics of these drugs with HSA. Herein we summarize the binding properties of some anti-cancer drugs by specifically looking into the binding site with HSA. The number of drugs binding at Sudlow's site I situated in subdomain II A is more than the drugs binding at Sudlow's site II.

Publisher

Bentham Science Publishers Ltd.

Subject

Cancer Research,Pharmacology,Molecular Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3